Off-label and unlicensed prescribing Stability studies of off-label and unlicensed drugs Antibiotic stewardship Pharmacist prescribing

Czarniak, P., M. R. Boddy, B. sunderland, and J. Hughes. 2016.“Stability studies of lincomycin hydrochloride in aqueous solution and intravenous infusion fluids.”Drug Design, Development and Therapy 10: 1029-1034. Alkhatib, L., R. W. Parsons, P. Czarniak, and V. B. Sunderland. 2015.“An evaluation of the reclassification of ophthalmic chloramphenicol for the management of acute bacterial conjunctivitis in community pharmacies in Western Australia.”International Journal of Pharmacy Practice 23 (2): 111-120. Czarniak, P., L. Bint, L. Favié, R. W. Parsons, J. Hughes, and V. B. Sunderland. 2015.“Clinical setting influences off-label and unlicensed prescribing in a paediatric teaching hospital.”PLoS One 10 (3). Qiu, W., K. Pham, I. James, D. Nolan, A. Castley, F. T. Christiansen, P. Czarniak, Y. Luo, J. Wu, M. J. Garlepp et al. 2013.“The influence of non-HLA gene polymorphisms and interactions on disease risk in a Western Australian multiple sclerosis cohort.”Journal of Neuroimmunology 261: 92-97. Benino, D., A. Girardi, and P. Czarniak. 2011.“Incorporating online teaching in an introductory pharmaceutical practice course: a study of student perceptions within an Australian University.”Pharmacy Practice 9 (4): 252-259.